Cargando…
Intravitreal dexamethasone implant therapy for the treatment of cystoid macular Oedema due to hydroxychloroquine retinopathy: a case report and literature review
BACKGROUND: Cystoid macular oedema (CMO) is an uncommon complication associated with hydroxychloroquine (HCQ) retinopathy threatening central vision. We report a patient with HCQ retinopathy and CMO, for which an intravitreal dexamethasone implant was used, which led to complete resolution of oedema...
Autores principales: | Ahn, Seong Joon, Joung, Jooyoung, Lee, Sang Hyup, Lee, Byung Ro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282365/ https://www.ncbi.nlm.nih.gov/pubmed/30522457 http://dx.doi.org/10.1186/s12886-018-0985-x |
Ejemplares similares
-
The effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case report
por: Hong, Eun Hee, et al.
Publicado: (2017) -
Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis
por: Majumder, Parthopratim Dutta, et al.
Publicado: (2016) -
Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema
por: Altintas, Ayse Gul Kocak, et al.
Publicado: (2019) -
Dexamethasone intravitreal implant in cystoid macular edema secondary to paclitaxel therapy
por: Burgos-Blasco, Barbara, et al.
Publicado: (2020) -
Repeat Intravitreal Dexamethasone Implant for Refractory Cystoid Macular Edema in Syphilitic Uveitis
por: Lautredou, Cassandra C., et al.
Publicado: (2018)